To test these hypotheses, we used a more sensitive method (i.e., a commercial multiplex Luminex-based panel) to simultaneously detect the concentration of IL-6, IL-8, and MCP-1 in both plasma and ADEs at various clinical stages of AD. The gene discussed is CCL2; the disease is Alzheimer disease.